New hope for ANCA vasculitis: experimental drug enters Mid-Stage trial

NCT ID NCT07160608

Recruiting now Disease control Sponsor: Alexion Pharmaceuticals, Inc. Source: ClinicalTrials.gov ↗

First seen Nov 01, 2025 · Last updated May 16, 2026 · Updated 35 times

Summary

This study tests a new drug called tarperprumig for people with ANCA-associated vasculitis, a rare disease where the immune system attacks blood vessels. The trial will include 75 adults with newly diagnosed or relapsing disease. Researchers aim to see if the drug is safe and can help bring the disease under control.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY-ASSOCIATED VASCULITIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Research Site
RECRUITING

Ciudad de Buenos Aires, C1015ABO, Argentina
Research Site
RECRUITING

Ciudad de Buenos Aires, C1181ACH, Argentina
Research Site
RECRUITING

La Plata, B1900AXI, Argentina
Research Site
RECRUITING

Rosario, S2000DEJ, Argentina
Research Site
RECRUITING

San Juan Bautista, 1888, Argentina
Research Site
WITHDRAWN

Santa Fe, S3000, Argentina
Research Site
NOT_YET_RECRUITING

Clayton, 3168, Australia
Research Site
RECRUITING

Heidelberg, 3084, Australia
Research Site
RECRUITING

Nedlands, 6009, Australia
Research Site
RECRUITING

Wollongong, 2500, Australia
Research Site
RECRUITING

Barretos, 14784-057, Brazil
Research Site
RECRUITING

Belo Horizonte, 30130-100, Brazil
Research Site
RECRUITING

Porto Alegre, 90035-903, Brazil
Research Site
NOT_YET_RECRUITING

Recife, 50670-420, Brazil
Research Site
RECRUITING

São Paulo, 01323-001, Brazil
Research Site
RECRUITING

São Paulo, 04038-002, Brazil
Research Site
RECRUITING

São Paulo, 05430-010, Brazil
Research Site
NOT_YET_RECRUITING

Calgary, Alberta, T2N 1N4, Canada
Research Site
RECRUITING

Edmonton, Alberta, T6G 2X8, Canada
Research Site
RECRUITING

Etobicoke, Ontario, M9W 6V1, Canada
Research Site
NOT_YET_RECRUITING

Hamilton, Ontario, L8N 4A6, Canada
Research Site
RECRUITING

Toronto, Ontario, M5T 3L9, Canada
Research Site
NOT_YET_RECRUITING

Montreal, Quebec, H4J 1C5, Canada
Research Site
NOT_YET_RECRUITING

Baotou, 014010, China
Research Site
RECRUITING

Beijing, 100034, China
Research Site
NOT_YET_RECRUITING

Beijing, 100730, China
Research Site
RECRUITING

Guangzhou, 510080, China
Research Site
NOT_YET_RECRUITING

Hangzhou, 310003, China
Research Site
NOT_YET_RECRUITING

Nanchang, 330006, China
Research Site
NOT_YET_RECRUITING

Shenzhen, 518036, China
Research Site
RECRUITING

Marseille, 13385, France
Research Site
RECRUITING

Paris, 75014, France
Research Site
RECRUITING

Paris, 75015, France
Research Site
RECRUITING

Strasbourg, 67091, France
Research Site
RECRUITING

Toulouse, 31059, France
Research Site
RECRUITING

Berlin, 10117, Germany
Research Site
RECRUITING

Essen, 45147, Germany
Research Site
RECRUITING

Göttingen, 37075, Germany
Research Site
RECRUITING

Ludwigshafen, 67063, Germany
Research Site
RECRUITING

München, 81377, Germany
Research Site
RECRUITING

Brescia, 25123, Italy
Research Site
RECRUITING

Padova, 35128, Italy
Research Site
RECRUITING

Pavia, 27100, Italy
Research Site
RECRUITING

Pisa, 56126, Italy
Research Site
RECRUITING

Gdansk, 80-214, Poland
Research Site
RECRUITING

Krakow, 30-688, Poland
Research Site
RECRUITING

Poznan, 60-355, Poland
Research Site
RECRUITING

Warsaw, 04-141, Poland
Research Site
WITHDRAWN

Daegu, 41944, South Korea
Research Site
RECRUITING

Daegu, 42472, South Korea
Research Site
RECRUITING

Daejeon, 35015, South Korea
Research Site
RECRUITING

Seoul, 03080, South Korea
Research Site
RECRUITING

Seoul, 03722, South Korea
Research Site
RECRUITING

Seoul, 04763, South Korea
Research Site
RECRUITING

Seoul, 08308, South Korea
Research Site
RECRUITING

Seoul, 135-710, South Korea
Research Site
RECRUITING

Wŏnju, 26426, South Korea
Research Site
RECRUITING

Barcelona, 08036, Spain
Research Site
RECRUITING

Pamplona, 31008, Spain
Research Site
RECRUITING

San Sebastián de los Reyes, 28702, Spain
Research Site
RECRUITING

Santander, 39008, Spain
Research Site
RECRUITING

Seville, 41013, Spain
Research Site
RECRUITING

Kaohsiung City, 81362, Taiwan
Research Site
RECRUITING

Taichung, 40705, Taiwan
Research Site
RECRUITING

Taipei, 114, Taiwan
Research Site
RECRUITING

Taoyuan, 333, Taiwan
Research Site
RECRUITING

Altındağ, 06230, Turkey (Türkiye)
Research Site
RECRUITING

Ankara, 5000, Turkey (Türkiye)
Research Site
RECRUITING

Center, 23200, Turkey (Türkiye)
Research Site
RECRUITING

Istanbul, 34098, Turkey (Türkiye)
Research Site
RECRUITING

Istanbul, Turkey (Türkiye)
Research Site
RECRUITING

Kocaeli, 41380, Turkey (Türkiye)
Research Site
RECRUITING

Birmingham, B15 2GW, United Kingdom
Research Site
RECRUITING

Cambridge, CB2 0QQ, United Kingdom
Research Site
NOT_YET_RECRUITING

Leicester, LE5 4PW, United Kingdom
Research Site
NOT_YET_RECRUITING

London, NW3 2QG, United Kingdom
Research Site
NOT_YET_RECRUITING

London, W12 0HS, United Kingdom
Research Site
NOT_YET_RECRUITING

Manchester, M13 9WL, United Kingdom

Conditions

Explore the condition pages connected to this study.

ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY-ASSOCIATED VASCULITIS ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY-ASSOCIATED VASCULITIS